JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy.
about
CMX001 (1-O-hexadecyloxypropyl-cidofovir) inhibits polyomavirus JC replication in human brain progenitor-derived astrocytesPolyomaviruses and disease: is there more to know than viremia and viruria?T cell epitope mapping of JC polyoma virus-encoded proteome reveals reduced T cell responses in HLA-DRB1*04:01+ donorsProgressive multifocal leukoencephalopathy in HIV-1 infection.Immune response to JC virus T antigen in patients with and without colorectal neoplasia.Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB™) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-infectionRearranged JC virus noncoding control regions found in progressive multifocal leukoencephalopathy patient samples increase virus early gene expression and replication rateJC Virus Leuko-Encephalopathy in Reduced Intensity Conditioning Cord Blood Transplant Recipient with a Review of the Literature.Seroepidemiology of Human Polyomaviruses in a US Population.The rapidly expanding family of human polyomaviruses: recent developments in understanding their life cycle and role in human pathology.Reevaluating and optimizing polyomavirus BK and JC real-time PCR assays to detect rare sequence polymorphisms.JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individuals.Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS.Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy.BK virus capsid antibodies are associated with protection against subsequent development of PML in HIV-infected patients.Changes in JC virus-specific T cell responses during natalizumab treatment and in natalizumab-associated progressive multifocal leukoencephalopathy.Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathyType I Interferons Regulate the Magnitude and Functionality of Mouse Polyomavirus-Specific CD8 T Cells in a Virus Strain-Dependent MannerImmune recovery in HIV-infected patients after Candida esophagitis is impaired despite long-term antiretroviral therapyReactivation of human polyomaviruses in immunocompromised states.The link between VLA-4 and JC virus reactivation.The human JC polyomavirus (JCPyV): virological background and clinical implications.Immunology of progressive multifocal leukoencephalopathy.B cells and progressive multifocal leukoencephalopathy: search for the missing linkProgressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS).Treatment options for progressive multifocal leukoencephalopathy in HIV-infected persons: current status and future directions.45 years after the discovery of human polyomaviruses BK and JC: Time to speed up the understanding of associated diseases and treatment approaches.Distribution and genetic diversity of the human polyomaviruses JC and BK in surface water and sewage treatment plant during 2009 in Porto Alegre, Southern Brazil.Molecular detection and characterization of BK and JC polyomaviruses in urine samples of renal transplant patients in Southern Brazil.Inter- and intralaboratory comparison of JC polyomavirus antibody testing using two different virus-like particle-based assays.Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome.Continued declining incidence and improved survival of progressive multifocal leukoencephalopathy in HIV/AIDS patients in the current era.Cohort profile: the Swiss HIV Cohort study.
P2860
Q24599841-C98F4B72-A5B0-4BB7-ADA0-5C972323B5C4Q28081350-42093605-870A-45EA-B2D4-F7F69DCE64F1Q28704590-660D03DD-4DA1-4C43-9B75-7D6508C25B91Q33506561-3908F242-219A-4793-A34B-C181CEF5D95AQ33915258-13E1F3E5-1B80-452B-815F-8F3F32297962Q34075008-8F8C8E1F-4DF3-44DA-8C37-165B21837A89Q34178250-6878E644-5A0A-440A-B9DB-DB2646B2436BQ34343528-1A7A28FB-A783-4999-9C30-A681B41F679AQ34505098-FB741C65-B16A-41AC-BC56-F72FF9B8B023Q34629128-577005AB-1BAB-4670-805D-41E5F64E9667Q35066928-F9687B85-05A1-4213-A44B-7F15DB2B888FQ35194420-27E4E36A-04B1-4084-AEF8-0BCFC9B45D1FQ35609239-6B177828-DC7D-4E37-B3EE-C61F99C1CDE2Q35675602-91BAA09C-FF80-4575-B113-AE1F377B5360Q36202667-030DAD18-FB57-4B8E-B8F7-3659CF98A5C1Q36384476-4A920C32-4E70-4721-AF5D-5A5BB5A8CDBCQ36764988-959D0EE4-F576-4E24-8DC4-C3D9456425C1Q36878949-2025DB51-FE9C-4DF6-B3D9-0814F00CC7ADQ37104112-ACA05FA9-3A1D-4409-BF71-53F2E78CA11AQ37725435-9F36DA5A-2768-4EAA-AC01-AC4C80C62CB9Q37965603-349F424B-F823-4405-AF10-05E5779ECF89Q38115572-67E160F5-18DF-4601-9E92-78BF983C561FQ38367755-268941D7-F08E-4149-8783-15FD688C0F91Q38515349-62D0B85E-5BC7-49CC-95E9-3514D14C34CEQ38577593-F1E3C775-A312-41CE-9A77-94634F150FACQ38665891-3BD26D92-4E35-4643-A8C3-3CBFFA43466FQ38801394-09F8F780-EDE8-47B0-BEC5-230AD854A195Q40408813-8E553E41-B8FF-4E4E-8D83-ADA997F9170FQ41532326-63C7187A-E994-418E-9165-0A200FD0B12DQ41727049-0EA8D819-2C85-4A78-8BB2-6BDC29BE86D2Q41906877-B98565DD-C158-4C06-8F84-2D0ECAC09B28Q42251011-49A9B33F-D145-4FC5-A5B0-0DE785881A97Q46959264-EA9EB611-C2DE-4874-B877-B93E426B392E
P2860
JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
JC virus-specific immune respo ...... ultifocal leukoencephalopathy.
@en
JC virus-specific immune respo ...... ultifocal leukoencephalopathy.
@nl
type
label
JC virus-specific immune respo ...... ultifocal leukoencephalopathy.
@en
JC virus-specific immune respo ...... ultifocal leukoencephalopathy.
@nl
prefLabel
JC virus-specific immune respo ...... ultifocal leukoencephalopathy.
@en
JC virus-specific immune respo ...... ultifocal leukoencephalopathy.
@nl
P2093
P2860
P50
P356
P1433
P1476
JC virus-specific immune respo ...... ultifocal leukoencephalopathy.
@en
P2093
Christian Garzoni
Christoph A Fux
Hans H Hirsch
Marcel Wolbers
Nicolas J Mueller
Nina Khanna
Pietro Vernazza
Raphael Viscidi
Renaud A Du Pasquier
P2860
P304
P356
10.1128/JVI.02657-08
P407
P577
2009-02-11T00:00:00Z